Teva Quits PhRMA As Financial, Policy Challenges Loom For The Brand/Generic Hybrid Giant

 
• By Derrick Gingery
  
Teva and PhRMA are going their separate ways in 2023. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legislation

More from Pink Sheet